Insights

Clinical pipeline Peel Therapeutics is a small to mid-sized biotech focused on cancer and inflammatory diseases with a near-term clinical-stage pipeline, presenting opportunities to engage with translational and clinical development partners, CROs, and potential collaborators for trial support, diagnostics integration, and formulation optimization.

Peel Therapeutics Tech Stack

Peel Therapeutics uses 8 technology products and services including Amazon Web Services, gstatic.com, cdnjs, and more. Explore Peel Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • gstatic.com
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Microsoft 365
    Email
  • Google Cloud
    Infrastructure As A Service
  • TweenMax
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Polyfill
    Javascript Libraries

Media & News

Peel Therapeutics's Email Address Formats

Peel Therapeutics uses at least 1 format(s):
Peel Therapeutics Email FormatsExamplePercentage
FLast@peeltx.comJDoe@peeltx.com
100%

Frequently Asked Questions

What is Peel Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Peel Therapeutics's official website is peeltx.com and has social profiles on LinkedIn.

What is Peel Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Peel Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Peel Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Peel Therapeutics has approximately 13 employees across 2 continents, including North AmericaAsia. Key team members include Principal: J. M.. Explore Peel Therapeutics's employee directory with LeadIQ.

What industry does Peel Therapeutics belong to?

Minus sign iconPlus sign icon
Peel Therapeutics operates in the Biotechnology Research industry.

What technology does Peel Therapeutics use?

Minus sign iconPlus sign icon
Peel Therapeutics's tech stack includes Amazon Web Servicesgstatic.comcdnjsMicrosoft 365Google CloudTweenMaxjQuery MigratePolyfill.

What is Peel Therapeutics's email format?

Minus sign iconPlus sign icon
Peel Therapeutics's email format typically follows the pattern of FLast@peeltx.com. Find more Peel Therapeutics email formats with LeadIQ.

How much funding has Peel Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Peel Therapeutics has raised $25M in funding. The last funding round occurred on Feb 18, 2025.
Peel Therapeutics logo

Peel Therapeutics

Biotechnology ResearchUtah, United States11-50 Employees

Peel Therapeutics is a biotechnology research company based in Salt Lake City, Utah. It focuses on translating evolutionary outliers into medicines for cancer and inflammatory diseases, addressing solubility, scalability, and bioavailability in its clinical-stage pipeline. In April 2023, Peel Therapeutics announced the development of first-in-class neutrophil-targeting peptides derived from natural NET inhibitors found in newborns to block inflammation linked to immunothrombosis and fibrosis. The company appears to operate with a relatively small to mid-sized team within the biotechnology sector. Peel Therapeutics is positioned at the intersection of biology and drug development, pursuing therapies through biotech research methods.

Section iconCompany Overview

Website
peeltx.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $25M

    Peel Therapeutics has raised a total of $25M of funding over 7 rounds. Their latest funding round was raised on Feb 18, 2025as a series_a.

  • $10M$25M

    Peel Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $25M

    Peel Therapeutics has raised a total of $25M of funding over 7 rounds. Their latest funding round was raised on Feb 18, 2025as a series_a.

  • $10M$25M

    Peel Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.